{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T16:28:06Z","timestamp":1793550486892,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["BU 2722 \/2-3"],"award-info":[{"award-number":["BU 2722 \/2-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["HA 6880 \/2-3"],"award-info":[{"award-number":["HA 6880 \/2-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jtauto.2026.100396","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:08:56Z","timestamp":1787670536000},"page":"100396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Late TNF\u03b1 blockade is associated with systemic immune rewiring without disease control in established experimental autoimmune hepatitis"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0051-2044","authenticated-orcid":false,"given":"Laura Elisa","family":"Buitrago-Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7332-7245","authenticated-orcid":false,"given":"Zexuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4023-0006","authenticated-orcid":false,"given":"Ziting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2906-0480","authenticated-orcid":false,"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-8692","authenticated-orcid":false,"given":"Fatih","family":"Noyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2827-7787","authenticated-orcid":false,"given":"Matthias","family":"Hardtke-Wolenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtauto.2026.100396_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","article-title":"EASL clinical practice guidelines on the management of autoimmune hepatitis","volume":"83","author":"Dalekos","year":"2025","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100396_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100396_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cld.2014.09.004","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"19","author":"Czaja","year":"2015","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100396_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cgh.2015.09.037","article-title":"Efficacy of 6-Mercaptopurine as second-line treatment for patients with autoimmune hepatitis and Azathioprine intolerance","volume":"14","author":"Hubener","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100396_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jhepr.2019.10.005","article-title":"Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: results from the International Autoimmune Hepatitis group","volume":"1","author":"Than","year":"2019","journal-title":"JHEP Rep."},{"issue":"11","key":"10.1016\/j.jtauto.2026.100396_bib6","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1038\/ajg.2009.433","article-title":"A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-Alpha blockade","volume":"104","author":"Weiler-Normann","year":"2009","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100396_bib7","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1097\/HEP.0000000000001089","article-title":"Efficacy and safety of Infliximab in patients with autoimmune hepatitis","volume":"81","author":"Efe","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100396_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2026.02.026","article-title":"Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitis","author":"Xu","year":"2026","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100396_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-Mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.jtauto.2026.100396_bib10","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.4049\/jimmunol.180.10.6467","article-title":"Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells:: applicability to tumor-infiltrating T regulatory cells","volume":"180","author":"Chen","year":"2008","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100396_bib11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrd3030","article-title":"TNF receptor 2 pathway: drug target for autoimmune diseases","volume":"9","author":"Faustman","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100396_bib12","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.23792","article-title":"A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis","volume":"52","author":"Ferri","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jtauto.2026.100396_bib13","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jhep.2014.05.034","article-title":"Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies","volume":"61","author":"Taubert","year":"2014","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100396_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency","volume":"57","author":"Peiseler","year":"2012","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100396_bib15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/hep.26380","article-title":"Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells","volume":"58","author":"Hardtke-Wolenski","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100396_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2016.12.001","article-title":"The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development","volume":"78","author":"Hardtke-Wolenski","year":"2017","journal-title":"J. Autoimmun."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100396_bib17","article-title":"From model to man: understanding Tregs' dual role in MASLD","volume":"7","author":"Dywicki","year":"2025","journal-title":"JHEP Rep."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100396_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/hep4.1807","article-title":"The detrimental role of regulatory T cells in nonalcoholic steatohepatitis","volume":"6","author":"Dywicki","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jtauto.2026.100396_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102591","article-title":"Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis","volume":"117","author":"Buitrago-Molina","year":"2021","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100396_bib20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/HEP.0000000000000589","article-title":"AIHSG Dutch, G International autoimmune hepatitis, AIHSG Dutch, and G International autoimmune hepatitis, lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry","volume":"79","author":"Slooter","year":"2024","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jtauto.2026.100396_bib21","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jhep.2017.11.020","article-title":"Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis","volume":"68","author":"Hartl","year":"2018","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100396_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061471","article-title":"Anti-CD20 therapy alters the protein signature in experimental Murine AIH, but not exclusively towards regeneration","volume":"10","author":"Buitrago-Molina","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.jtauto.2026.100396_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100396_bib24","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.cgh.2014.07.062","article-title":"Risk of drug-induced liver injury from tumor necrosis factor antagonists","volume":"13","author":"Bj\u00f6rnsson","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T15:43:34Z","timestamp":1793547814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909026000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":24,"alternative-id":["S2589909026000493"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100396","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late TNF\u03b1 blockade is associated with systemic immune rewiring without disease control in established experimental autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100396"}}